From the Divisions of Cardiovascular Medicine (I.F., A.E.G.) and Clinical Pharmacology (S.R., A.M., I.B.) and the Departments of Medicine (I.F., A.E.G., I.B.) and Pharmacology (S.R., A.M., I.B.), Vanderbilt University, Nashville, Tenn; and the Department of Drug Research and Pharmacological Sciences (H.Z., D.Z.), CV Therapeutics, Inc, Palo Alto, Calif. (At 2004-11)